Literature DB >> 7570439

Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis.

C T Yu1, C H Wang, T J Huang, H C Lin, H P Kuo.   

Abstract

BACKGROUND: Effective host defence against mycobacterial infection chiefly depends on the interactions between macrophages and T lymphocytes. This study investigated the relation of cellular components and their activity of cells obtained by bronchoalveolar lavage (BAL) from the lower respiratory tract to disease regression in patients with active pulmonary tuberculosis without HIV infection.
METHODS: Clinical indices including age, sex, the presence of diabetes, fever, the presence of resistant strains of mycobacteria, the bacterial load in sputum, and disease extent on chest radiography at presentation were assessed before commencing four-drug antituberculous therapy. Twenty two patients with active pulmonary tuberculosis were divided into rapid, intermediate, and slow regression groups. Subpopulations of alveolar macrophages separated using discontinuous Percoll density gradient centrifugation and T lymphocytes (with CD3, CD4, CD8, and CD25 monoclonal antibodies) were quantified.
RESULTS: There were no differences among rapid, intermediate, and slow regression groups in terms of age, sex, the presence of diabetes, the presence of resistant strains of mycobacteria, or the bacterial load in sputum. No differences were found between the groups in terms of subpopulations of alveolar macrophages or numbers of CD3 and CD4 lymphocytes. By contrast, an increase in CD8 cells was shown in the slow regression group compared with the rapid and intermediate regression groups. CD25 cell numbers were increased in the rapid regression group compared with the slow regression group. The CD4/CD8 ratio was decreased in the slow regression group compared with the rapid and intermediate regression groups and the relation between the proportion of CD25 cells and the CD4/CD8 ratio in BAL fluid was significant.
CONCLUSIONS: A decreased CD4/CD8 ratio with an increase in CD8 cells in the alveolar spaces was associated with slow disease regression in patients with active pulmonary tuberculosis without HIV infection, suggesting that the balance of T lymphocyte subsets may play a central part in the modulation of host defence against mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570439      PMCID: PMC474909          DOI: 10.1136/thx.50.8.869

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Pleural fluid and peripheral blood lymphocyte function in tuberculosis.

Authors:  J J Ellner
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

2.  T-cell differentiation antigens and antigenic lymphocyte reactivity in pleural effusions.

Authors:  M R Simon; S G Desai; J Jennings; D Engel
Journal:  Asian Pac J Allergy Immunol       Date:  1986-06       Impact factor: 2.310

3.  Radiology in epidemiological studies and some therapeutic trials.

Authors:  G Simon
Journal:  Br Med J       Date:  1966-08-27

4.  Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis.

Authors:  H P Kuo; C T Yu
Journal:  Chest       Date:  1993-12       Impact factor: 9.410

5.  Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes.

Authors:  P Katz; R A Goldstein; A S Fauci
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

7.  Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects.

Authors:  P Godard; J Chaintreuil; M Damon; M Coupe; O Flandre; A Crastes de Paulet; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1982-08       Impact factor: 10.793

8.  T4 lymphopenia in patients with active pulmonary tuberculosis.

Authors:  J S Beck; R C Potts; T Kardjito; J M Grange
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Increase in T cells bearing IgG Fc receptors in peripheral blood of patients with tuberculosis by in vitro stimulation with purified protein derivative.

Authors:  I Tsuyuguchi; H Shiratsuchi; O Teraoka; T Hirano
Journal:  Am Rev Respir Dis       Date:  1980-06

10.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

Authors:  G A Rook; B R Champion; J Steele; A M Varey; J L Stanford
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

View more
  6 in total

1.  In situ activation of helper T cells in the lung.

Authors:  B Raju; C F Tung; D Cheng; N Yousefzadeh; R Condos; W N Rom; D B Tse
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Lymphocyte subpopulations in pulmonary tuberculosis patients.

Authors:  Figen Deveci; H Handan Akbulut; Ilhami Celik; M Hamdi Muz; Fulya Ilhan
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 4.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

Review 5.  A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.

Authors:  Jamilah Meghji; Hope Simpson; S Bertel Squire; Kevin Mortimer
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

6.  Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis.

Authors:  Srabanti Rakshit; Vasista Adiga; Soumya Nayak; Pravat Nalini Sahoo; Prabhat Kumar Sharma; Krista E van Meijgaarden; Anto Jesuraj Uk J; Chirag Dhar; George D Souza; Greg Finak; Stephen C De Rosa; Tom H M Ottenhoff; Annapurna Vyakarnam
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.